Evrysdi leads latest CHMP recommendations
The Committee has recommended six medicines for approval at its February 2021 meeting
Read More
Tag: Approvals
Kesimpta and Vazkepa among latest CHMP recommendations
Bumper meeting saw 13 new medicines recommended for approval
Read More
New cancer drugs taking longer to reach NHS patients
A new report by The Institute of Cancer Research (ICR) has found that NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use.
Read More
US beats EU on drug review times, approvals
US regulators have outpaced their European counterparts both on the number of new medicines approved and length of review times between 2011 and 2015, shows a new analysis published by the New England Journal of Medicine.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
